Physician profile
Michael D Hold
NPI 1851595425
$2,108.58
in general payments reported to CMS, 2019-2025
28 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $310 · 2020: $153 · 2021: $364 · 2022: $313 · 2023: $499 · 2024: $321 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $956 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $955.82 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $547.43 | 2019-2024 | |
| Evofem Biosciences, INC. | $308.14 | 2021-2025 | Phexxi, Solosec, Phexx |
| Sumitomo Pharma America, INC. | $151.22 | 2023-2025 | Myfembree |
| Ethicon US, LLC | $121.77 | 2019-2024 | Ethicon, Stratafix, Evarrest |
| Pfizer INC. | $109.33 | 2022-2023 | |
| Organon LLC | $105.75 | 2021-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $99.88 | 2023-2024 | |
| Avion Pharmaceuticals | $95.29 | 2019-2021 | |
| Astellas Pharma US INC | $81.33 | 2023-2024 | Veozah |
| Myovant Sciences INC. | $68.73 | 2021-2022 | |
| Shield Therapeutics INC | $40.97 | 2024-2025 | |
| Exact Sciences Corporation | $38.30 | 2023-2024 | Cologuard Collection Kit |
| Coopersurgical, INC. | $33.03 | 2021 | |
| Therapeuticsmd, INC. | $32.36 | 2020-2022 | |
| Ascend Therapeutics US, LLC | $28.84 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien Lp | $27.51 | 2019 | |
| Duchesnay USA Incorporated | $23.82 | 2019 | |
| Meditrina | $22.55 | 2023 | |
| Hologic Sales and Service, LLC | $20.87 | 2019 | |
| Biom'Up France Sas | $20.83 | 2020 | |
| Mylan Pharmaceuticals INC. | $18.55 | 2022 | |
| Medicem INC. | $18.43 | 2020 | |
| Biom'Up Sa | $17.89 | 2019 | |
| Allergan, INC. | $17.71 | 2019 | |
| Mimedx Group, INC. | $15.35 | 2025 | |
| Exeltis, USA INC. | $15.12 | 2025 | Slynd |
| Vertical Pharmaceuticals, LLC | $14.23 | 2019 | |
| Millicent US INC | $13.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.